LifeMD, Inc. Common Stock (LFMD) Stock Price

LFMDStock

$2.34−63.61%52W

Market Cap$112.92M

P/E7.86x

PEG Ratio—

Div yield—

Beta2.11

LFMD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-47.84%

Price vs S&P 500 (4W)-26.12%

VGM Score38.49

P/E Ratio (Annual)7.86x

P/CF (Annual)13.62x

Book Value / Share (Quarterly)$0.17

P/TBV (Annual)13.36x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)17.70%

Cash Flow / Share (Quarterly)$-0.35

Price vs S&P 500 (YTD)-43.30%

Gross Margin (TTM)69.37%

Net Profit Margin (TTM)0.10%

EPS (TTM)$0.01

10-Day Avg Trading Volume0.70M

EPS Excl Extra (TTM)$0.01

Revenue Growth (5Y)39.07%

EPS (Annual)$0.32

Dividend / Share (Annual)$0.07

ROI (Annual)61.99%

Gross Margin (Annual)85.72%

Net Profit Margin (5Y Avg)-23.99%

Cash / Share (Quarterly)$0.53

P/E Basic Excl Extra (TTM)561.12x

Revenue Growth QoQ (YoY)-24.01%

P/E Normalized (Annual)7.86x

ROA (Last FY)20.39%

Revenue Growth TTM (YoY)-16.73%

EBITD / Share (TTM)$-0.52

ROE (5Y Avg)-1045.29%

Operating Margin (TTM)-12.42%

Cash Flow / Share (Annual)$-0.03

P/B Ratio14.16x

P/B Ratio (Quarterly)25.07x

Net Income / Employee (Annual)$41,400

EV / Revenue (TTM)0.43x

Net Interest Coverage (TTM)-6.48x

ROA (TTM)0.30%

EV / EBITDA (TTM)287.20x

EPS Incl Extra (Annual)$0.32

Current Ratio (Annual)1.25x

Quick Ratio (Quarterly)0.84x

3-Month Avg Trading Volume0.88M

52-Week Price Return-63.61%

EV / Free Cash Flow (Annual)27.59x

P/E Incl Extra (TTM)561.12x

Revenue / Employee (TTM)$589,300

Tangible BV / Share (Quarterly)$0.08

P/S Ratio (Annual)0.58x

Asset Turnover (Annual)2.76x

52-Week High$6.53

Operating Margin (5Y Avg)-24.62%

EPS Excl Extra (Annual)$0.32

CapEx CAGR (5Y)88.50%

26-Week Price Return-37.93%

Quick Ratio (Annual)1.18x

13-Week Price Return-43.61%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.90x

Enterprise Value$87.65M

Revenue / Share Growth (5Y)10.51%

Asset Turnover (TTM)3.07x

Book Value / Share Growth (5Y)37.77%

Revenue / Employee (Annual)$559,200

Inventory Turnover (Annual)9.95x

Pretax Margin (Annual)-5.25%

Cash / Share (Annual)$0.79

3-Month Return Std Dev61.25%

Gross Margin (5Y Avg)80.22%

Net Income / Employee (TTM)$600

ROE (Last FY)61.99%

Net Interest Coverage (Annual)-0.22x

EPS Basic Excl Extra (Annual)$0.32

P/FCF (TTM)14.36x

Receivables Turnover (TTM)22.00x

EV / Free Cash Flow (TTM)668.20x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$0.01

Receivables Turnover (Annual)19.64x

ROI (TTM)1.69%

P/S Ratio (TTM)0.55x

Pretax Margin (5Y Avg)-26.17%

Revenue / Share (Annual)$4.30

Tangible BV / Share (Annual)$0.26

Forward P/E3.77x

Free OCF CAGR (5Y)88.70%

Price vs S&P 500 (52W)-79.14%

P/E Ratio (TTM)561.12x

Year-to-Date Return-31.38%

5-Day Price Return-8.24%

EPS Normalized (Annual)$0.32

ROA (5Y Avg)-68.44%

Net Profit Margin (Annual)7.40%

Month-to-Date Return-19.31%

Cash Flow / Share (TTM)$-0.72

EBITD / Share (Annual)$-0.18

Operating Margin (Annual)-4.55%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)30.34x

ROI (5Y Avg)-622.90%

P/E Excl Extra (TTM)561.12x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.01

P/TBV (Quarterly)44.13x

Payout Ratio (Annual)21.64%

P/B Ratio (Annual)7.09x

Dividend / Share (TTM)$0.07

Inventory Turnover (TTM)7.36x

Pretax Margin (TTM)-12.41%

Book Value / Share (Annual)$0.50

Price vs S&P 500 (13W)-46.30%

Dividend Yield (TTM)2.75%

Beta2.11x

P/FCF (Annual)18.86x

Revenue / Share (TTM)$4.28

ROE (TTM)1.69%

52-Week Low$2.34

vGradeC

gGradeC

mGradeF

vgmGradeD

LFMD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.04	-$0.15	-229.56%(-$0.10)
Q1 2026	May 6, 2026	-$0.13	-$0.15	-21.28%(-$0.03)
Q4 2025	Mar 9, 2026	$0.09	$0.06	-36.89%(-$0.03)
Q3 2025	Nov 17, 2025	$0.04	-$0.08	-285.11%(-$0.13)
Q2 2025	Aug 5, 2025	$0.18	-$0.01	-106.22%(-$0.19)

LFMD Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.14

Industry Peers — Physicians' Offices(15)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	Revenue Growth TTM (YoY)	Operating Margin (TTM)	ROE (TTM)	Price
LFMDLifeMD, Inc. Common Stock	C	C	F	7.9x	-16.7%	-12.4%	1.7%	$2.34
HIMSHims & Hers Health, Inc.	D	B	D	51.0x	28.0%	-6.0%	-30.0%	$28.07
TDOCTeladoc Health, Inc.	A	C	D	—	-2.1%	-7.5%	-13.1%	$5.67
TOIThe Oncology Institute, Inc. Common Stock	D	A	A	—	35.4%	-6.0%	-482.6%	$7.05
STLNStarling Oncology, Inc. Common Stock	F	A	D	—	38.4%	-4.4%	-482.6%	$6.43
SBCSBC Medical Group Holdings Incorporated Common Stock	B	C	B	10.4x	-6.9%	37.3%	19.3%	$5.16
AUNAAuna S.A.	A	D	C	13.9x	7.8%	13.4%	0.9%	$5.32
AIRSAirSculpt Technologies, Inc. Common Stock	C	F	F	—	-8.7%	-8.3%	-12.5%	$1.27
WSTNWestin Acquisition Corp Class A Ordinary Share	—	—	C	—	—	—	—	$10.21
CCMConcord Medical Services Holding Limited	B	A	D	—	40.1%	-45.0%	-11.6%	$3.63
BMGLBasel Medical Group Ltd Ordinary Shares	C	A	D	—	29.8%	-55.9%	-178.8%	$3.95
SBCWWSBC Medical Group Holdings Incorporated Warrants	—	—	A	—	—	—	—	$0.42
STLNWStarling Oncology, Inc. Warrant	—	—	F	—	—	—	—	$0.02
TOIIWThe Oncology Institute, Inc. Warrant	—	—	F	—	—	—	—	$0.02
WSTNRWestin Acquisition Corp Right	—	—	C	—	—	—	—	$0.16
WSTNUWestin Acquisition Corp Units	—	—	C	—	—	—	—	$10.34

About LifeMD, Inc. Common Stock

LifeMD Inc is a direct-to-patient telehealth platform that integrates electronic medical records, scheduling, remote lab testing, and cloud pharmacy services to deliver convenient, cost-effective virtual healthcare. The company generates revenue from both its core telehealth services and complementary offerings including nutritional supplements and over-the-counter products.